Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

NCT00528957 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tenofovir DF
DRUG: Zidovudine
DRUG: Stavudine

Sponsor

Gilead Sciences